+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "B Cell Maturation Antigen"

Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Hematologic Malignancies Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 111 Pages
  • Global
From
CAR T-Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

CAR T-Cell Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 111 Pages
  • Global
From
Cell-Based Immunotherapy Market - Growth, Trends, and Forecasts (2023 - 2028) - Product Thumbnail Image

Cell-Based Immunotherapy Market - Growth, Trends, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 110 Pages
  • Global
From
North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

North America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 70 Pages
  • North America
From
South & Central America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors) - Product Thumbnail Image

South & Central America T Cell Therapy Market Forecast to 2030 - Regional Analysis - by Modality (Research and Commercialized), Therapy Type [CAR T-cell Therapy and T-cell Receptor (TCR)-based], and Indication (Hematologic Malignancies and Solid Tumors)

  • Report
  • January 2024
  • 55 Pages
From
Asia Pacific Bispecific Antibodies Market Size, Share & Industry Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune Disorder and Others), By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Bispecific Antibodies Market Size, Share & Industry Trends Analysis Report By Indication (Cancer, Inflammatory & Autoimmune Disorder and Others), By Country and Growth Forecast, 2023 - 2030

  • Report
  • June 2023
  • 75 Pages
  • Asia Pacific
From
Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Regional Outlook and Forecast, 2022-2028 - Product Thumbnail Image

Cancer Gene Therapy Market Size, Share & Industry Trends Analysis Report By Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, and Gene Transfer), By End User, By Regional Outlook and Forecast, 2022-2028

  • Report
  • April 2022
  • 153 Pages
  • Global
From
T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

T-Cell therapy Market Size, Share & Industry Trends Analysis Report By End User (Hospitals and Cancer Treatment Centers), By Indication (Lymphoma, Acute Lymphocytic Leukemia and Others), By Therapy Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • June 2023
  • 263 Pages
  • Global
From
Cells Expressing Tumor Necrosis Factor Receptor Superfamily Member 17 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cells Expressing Tumor Necrosis Factor Receptor Superfamily Member 17 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 188 Pages
  • Global
From
Loading Indicator

The B Cell Maturation Antigen (BCMA) market is a subset of the oncology drugs market. BCMA is a protein found on the surface of B cells, a type of white blood cell. BCMA is a promising target for cancer immunotherapy, as it is expressed on multiple myeloma cells and other B-cell malignancies. BCMA-targeted therapies are designed to stimulate the body's immune system to recognize and attack cancer cells. BCMA-targeted therapies are being developed by a number of companies, including Amgen, Bristol-Myers Squibb, Celgene, Gilead Sciences, and Novartis. These companies are researching and developing BCMA-targeted therapies for multiple myeloma and other B-cell malignancies. Additionally, several clinical trials are underway to evaluate the safety and efficacy of BCMA-targeted therapies. Show Less Read more